SABR in High-Risk Prostate Cancer: Outcomes From 2 Prospective Clinical Trials With and Without Elective Nodal Irradiation-Reference-Cited by-同舟云学术

SABR in High-Risk Prostate Cancer: Outcomes From 2 Prospective Clinical Trials With and Without Elective Nodal Irradiation

Published:2019-05 Issue:1 Volume:104 Page:36-41
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Alayed Yasir,Cheung Patrick,Vesprini Danny,Liu Stanley,Chu William,Chung Hans,Musunuru Hima Bindu,Davidson Melanie,Ravi Ananth,Ho Ling,Deabreu Andrea,D'Alimonte Laura,Bhounr Zeeba,Zhang Liying,Commisso Kristina,Loblaw Andrew

Funder

Motorcycle Ride for Dad

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference26 articles.

1. Higher-than-conventional radiation doses in localized prostate cancer treatment: A meta-analysis of randomized, controlled trials;Viani;Int J Radiat Oncol,2009

2. Long-term results of conformal radiotherapy for prostate cancer: Impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes;Zelefsky;Int J Radiat Oncol,2008

3. Systematic review of the cost effectiveness of radiation therapy for prostate cancer from 2003 to 2013;Amin;Appl Health Econ Health Policy,2014

4. Stereotactic body radiotherapy for prostate cancer;Henderson;Clin Oncol,2015

5. Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials;Alayed;Radiother Oncol,2018

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional imaging guided stereotactic ablative body radiotherapy (SABR) with focal dose escalation and bladder trigone sparing for intermediate and high-risk prostate cancer: study protocol for phase II safo trial;Radiation Oncology;2024-05-03

2. Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in Spain;Cancers;2024-04-26

3. Towards optimal heterogeneous prostate radiotherapy dose prescriptions based on patient‐specific or population‐based biological features;Medical Physics;2024-01-15

4. Long-Term Outcomes Following Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy in High-Risk Prostate Cancer: Update From the FASTR/FASTR-2 Trials;Practical Radiation Oncology;2024-01

5. A Randomized Feasibility Trial of Stereotactic Prostate Radiation Therapy With or Without Elective Nodal Irradiation in High-Risk Localized Prostate Cancer (SPORT Trial);International Journal of Radiation Oncology*Biology*Physics;2023-11